ADM, Alzchem and Microsalt report facility investments and revenue growth amid rising demand for reformulation and creatine products.
ADM said it will invest $26 million to expand its Erlanger, Kentucky, facility and increase its capabilities by 40%. Alzchem has invested €120 million to construct a new production facility in Germany, while Microsalt said revenues jumped 280% to $2.1m last year.
4h ago · 2 sources
Coverage
- Inside ADM’s reformulation hub powering better-for-you innovation
Laurel Deppen / food_dive · 1d ago
- Microsalt revenues triple as major food players take interest
the_grocer · 1d ago